Inconsistent findings concerning the influence of FGFR2 gene G/A polymorphisms on breast cancer risk may be attributed to the heterogeneity of populations studied, variations in ethnic backgrounds and geographic locations, and potential sampling biases. The gene discussed is FGFR2; the disease is breast cancer.